ArticleFrontiers in immunology2026
Machine learning reveals an interleukin-33-associated immuno-metabolic axis defining recovery endotypes in severe combat trauma.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe combat trauma is associated with long-lasting systemic changes, yet standard anatomical injury scales may not adequately capture biological differences in patient recovery. To explore this variability, we analyzed the systemic molecular profiles of 53 combat trauma survivors during the rehabilitation phase and compared them to those of 46 uninjured active-duty military controls. Using a multidimensional biomarker panel (IL-33, ST2, TGF-β1, CTGF, galectin-3, heparan sulfate, NT-proBNP, and annexin A5) alongside routine clinical parameters, we applied unsupervised clustering and Random Forest machine learning to identify distinct patient endotypes. Our results showed that patients grouped into distinct molecular phenotypes, independent of their initial structural injury patterns. While localized structural injuries and associated infections (e.g., limb amputations) significantly influenced pro-fibrotic and pro-coagulant pathways, the overarching systemic features defining the machine-learning endotypes closely linked to an immuno-metabolic axis. This axis is characterized by elevated IL-33, endothelial glycocalyx shedding, and markers of metabolic, hepatic, and hematological strain (hemoglobin, white blood cells, AST, ALT, and total protein) rather than classical fibrotic markers. Notably, while circulating IL-33 levels varied significantly among patients, its soluble receptor, ST2, remained stable. These findings suggest that high-risk trauma patients may experience ongoing, ligand-driven systemic exhaustion. Integrating molecular endotyping into military medicine could improve clinical monitoring and guide targeted rehabilitation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.